eLaws | eCases | United States Code | Federal Courts |
Home » 2009 Issues » 74 FR (01/13/2009) » E9-451. Advisory Committees; Tentative Schedule of Meetings for 2009

  E9-451. Advisory Committees; Tentative Schedule of Meetings for 2009  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2009. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The IOM, at the request of the Commissioner, undertook a study of the use of the FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA Start Printed Page 1691advisory committees' Internet site located at http://www.fda.gov/​oc/​advisory/​default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

    The following list announces FDA's tentatively scheduled advisory committee meetings for 2009. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).

    Committee NameTentative Date of Meeting(s)Advisory Committee 10-Digit Information Line Code
    OFFICE OF THE COMMISSIONER
    Pediatric Advisory CommitteeMarch 23-24, June 22-23, September 21-22, December 7-88732310001
    Risk Communication Advisory CommitteeFebruary 26-27, April 30-May 1, August 13-14, November 12-138732112560
    Science Board to the Food and Drug AdministrationFebruary 24, May 18, August 17, November 163014512603
    CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
    Allergenic Products Advisory CommitteeMarch 5, October 223014512388
    Blood Products Advisory CommitteeJanuary 9, April 1, July 20-21, November 16-173014519516
    Cellular, Tissue and Gene Therapies Advisory CommitteeMay 14-15, November 5-63014512389
    Transmissible Spongiform Encephalopathies Advisory CommitteeTo be announced3014512392
    Vaccines and Related Biological Products Advisory CommitteeFebruary 18-19, May 20-21, September 23-24, November 18-193014512391
    CENTER FOR DRUG EVALUATION AND RESEARCH
    Anesthetic and Life Support Drugs Advisory CommitteeJanuary 29-30, April dates to be announced3014512529
    Anti-Infective Drugs Advisory CommitteeTo be announced3014512530
    Antiviral Drugs Advisory CommitteeTo be announced3014512531
    Arthritis Advisory CommitteeMarch 5, June 16-17, October 27-283014512532
    Cardiovascular and Renal Drugs Advisory CommitteeFebruary 3, March 18-19, July 28-29, December 7-83014512533
    Dermatologic and Ophthalmic Drugs Advisory CommitteeTo be announced3014512534
    Drug Safety and Risk Management Advisory CommitteeJanuary 30, April dates to be announced3014512535
    Endocrinologic and Metabolic Drugs Advisory CommitteeApril 2-33014512536
    Gastrointestinal Drugs Advisory CommitteeFebruary 173014512538
    Nonprescription Drugs Advisory CommitteeApril dates to be announced3014512541
    Oncologic Drugs Advisory CommitteeFebruary 25, March 24-25, May dates to be announced, July 14-15, September 15-16, December 16-173014512542
    Peripheral and Central Nervous System Drugs Advisory CommitteeJanuary 7-83014512543
    Pharmaceutical Science and Clinical Pharmacology, Advisory Committee forMarch dates to be announced3014512539
    Psychopharmacologic Drugs Advisory CommitteeMarch 263014512544
    Pulmonary-Allergy Drugs Advisory CommitteeFebruary 43014512545
    Reproductive Health Drugs, Advisory Committee forMay and August dates to be announced3014512537
    CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
    Device Good Manufacturing Practice Advisory CommitteeApril 15, October 5-63014512398
    Medical Devices Advisory Committee (Comprised of 18 Panels)
    Start Printed Page 1692
    Anesthesiology and Respiratory Therapy Devices PanelFebruary 5, April 30, July 23, September 17, November 123014512624
    Circulatory System Devices PanelFebruary 25, May 27, September 243014512625
    Clinical Chemistry and Clinical Toxicology Devices PanelMarch 18-19, June 17-18, October 21-223014512514
    Dental Products PanelFebruary 11, May 6, June 17, September 16, December 93014512518
    Ear, Nose, and Throat Devices PanelFebruary 24, May 19, August 18, November 173014512522
    Gastroenterology-Urology Devices PanelMarch 20, October 153014512523
    General and Plastic Surgery Devices PanelFebruary 26-27, June 9-10, October 15-163014512519
    General Hospital and Personal Use Devices PanelMarch 25-26, July 29-30, October 21-223014512520
    Hematology and Pathology Devices PanelApril 24, July 17, October 233014512515
    Immunology Devices PanelOctober 15-163014512516
    Medical Devices Dispute Resolution PanelMeetings occur as needed3014510232
    Microbiology Devices PanelFebruary 24-25, September 22-23, October 27-283014512517
    Molecular and Clinical Genetics PanelApril 15, October 5-63014510231
    Neurological Devices PanelFebruary 26-27, May 14-15, September 17-18, December 2-33014512513
    Obstetrics and Gynecology Devices PanelFebruary 5-6, May 14-15, August 13-14, November 12-133014512524
    Ophthalmic Devices PanelFebruary 12-13, May 14-15, September 24-25,November 19-203014512396
    Orthopaedic and Rehabilitation Devices PanelFebruary 3-4, April 14-15, June 9-10, August 11-12, October 15-16, December 1-23014512521
    Radiological Devices PanelFebruary 18, May 12, August 4, November 173014512526
    National Mammography Quality Assurance Advisory CommitteeNovember 4-53014512397
    Technical Electronic Product Radiation Safety Standards CommitteeNo meeting tentatively scheduled for 20093014512399
    CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
    Food Advisory CommitteeMay 20-213014510564
    CENTER FOR VETERINARY MEDICINE
    Veterinary Medicine Advisory CommitteeApril 143014512548
    NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR)
    Science Advisory Board to NCTRNovember 17-183014512559
    Start Signature

    Dated: December 24, 2008.

    Randall W. Lutter,

    Deputy Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. E9-451 Filed 1-12-09; 8:45 am]

    BILLING CODE 4160-01-S

Visit the Official Version
Leave a Comment

Document Information

Published:
01/13/2009
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E9-451
Pages:
1690-1692 (3 pages)
Docket Numbers:
Docket No. FDA-2008-N-0038
PDF File:
e9-451.pdf